AGAlexandre Gouzy

Alexandre Gouzy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexandre Gouzy has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Non-canonical peptidoglycan cross-linking is essential for Mycobacterium tuberculosis acid resistance

    by Ruoyao Ma, Daniel Rea, Karl Ocius, Ananya Naick, Claire Healy, Thomas R Ioerger, Marcos Pires, Felipe Cava, Sabine Ehrt, Alexandre Gouzy

    Mycobacterium tuberculosis withstands acidic conditions to survive and replicate within macrophages. To define the genetic determinants of this adaptation, we performed a transposon screen in a lipid-rich, acidic medium that mimics the host environment and supports robust M. tuberculosis growth. This screen identified ldtB , encoding an L,D-transpeptidase, as essential for growth and survival under acid stress. Loss of LdtB decreased 3–3 peptidoglycan cross-linking, disrupted cell wall architecture, and impaired intrabacterial pH homeostasis, resulting in increased susceptibility to cell wall–active antibiotics. Notably, M. tuberculosis lacking LdtB displayed heightened sensitivity to meropenem within macrophages, suggesting that targeting this enzyme could potentiate β-lactam efficacy during infection. These findings establish LdtB as a key mediator linking peptidoglycan homeostasis to acid stress resistance and underscores the importance of in vitro culture models that recapitulate the host microenvironment for uncovering new in vivo active therapeutic targets. Teaser: Disabling a key peptidoglycan cross-linking enzyme compromises M. tuberculosis survival under acidic stress and antibiotic exposure.


  • Open Access

    Metabolic control of drug resistance by a mycobacterial ion channel

    by Alexandre Gouzy, Shuqi Li, James Chen, Allen Na, Anas Saleh, Zachary A. Azadian, Kayan Tam, Vanisha Munsamy-Govender, Nicholas C. Poulton, Michael A. DeJesus, et al.

    Pyrazinamide (PZA) is a cornerstone of modern tuberculosis therapy. Yet its activity is highly context-dependent and poorly captured by standard in vitro assays, complicating both mechanistic studies and the detection of resistance. To address this gap, we develop a lipid-rich, acidic culture system that more closely recapitulates the host infection environment and enables robust, reproducible in vitro measurement of PZA activity. Using this platform, we demonstrate that acidic pH is essential for PZA-mediated killing, independent of bacterial replication. Integrating this system with genome-wide CRISPR interference profiling, comparative genomics, and metabolomics, we identify the previously uncharacterized ion channel Rv2571c as a clinically relevant determinant of PZA susceptibility. Rv2571c is structurally homologous to plant anion channels and facilitates the net efflux of α-ketoglutarate, a central TCA cycle metabolite. We show that α-ketoglutarate export sensitizes Mtb to PZA-induced cytoplasmic acidification, a critical step in bacterial killing. Loss of Rv2571c function confers PZA resistance in vitro , during macrophage infection, and in mice, whereas increased channel expression results in hypersusceptibility. Together, these findings reveal a metabolite-driven mechanism that links ion channel activity, central carbon metabolism, and cytoplasmic pH homeostasis to antibiotic susceptibility, providing a framework for improved detection of PZA resistance and the rational development of PZA-like therapeutics that shorten treatment.


  • Open Access

    Pyrazinamide kills Mycobacterium tuberculosis via pH-driven weak-acid permeation and cytosolic acidification

    by Janïs Laudouze, Tatyana I. Rokitskaya, Akira Abolet, Vanessa Point, Alexander M. Firsov, Ljudmila S. Khailova, Jean-François Cavalier, Stéphane Canaan, Alain R. Baulard, Yuri N. Antonenko, et al.

    Pyrazinamide (PZA) is a cornerstone drug in tuberculosis (TB) treatment with a strong bactericidal activity in vivo on both actively and non-replicating bacterial subpopulations. Yet the precise mode of action of its active form, pyrazinoic acid (HPOA), remains unclear. In this study, we comprehensively explore and challenge the two major and conflicted models of PZA mode of action. The pH-dependent model, where the drug is mostly effective at acidic pH by acidifying Mycobacterium tuberculosis ( Mtb ) cytosol, and the PanD-dependent model where PZA’s active form targets the aspartate decarboxylase PanD, therefore depleting pantothenate and subsequently coenzyme A (CoA) levels regardless of the surrounding pH. By combining standard antimicrobial susceptibility testing at various pH with fluorescence-based live recording of Mtb intrabacterial pH, we demonstrate that PZA kills Mtb by decreasing intrabacterial pH, independently of pantothenate levels. Comparative studies between a prototrophic Mtb strain and a pantothenate auxotrophic mutant lacking the panCD locus confirmed that PZA bactericidal activity is primarily driven by pH and its ability to acidify Mtb cytosol, independently of the aspartate decarboxylase PanD. Bio-electrophysiology experiments revealed that acidic pH promotes the conversion of the pyrazinoate anion POA⁻ into HPOA which in turn acts as conventional weak acid that facilitates membrane permeation and cytosolic acidification. Finally, using custom-based culture media, we demonstrate that PZA displays heterogeneous efficacy according to the media composition, therefore proposing a revisited biological model that might explain the discrepancies around PZA’s unique mode of action. Overall, this work constitutes the first comprehensive side-by-side investigation of the two models and univocally supports a pH-dependent mechanism of action underlying PZA sterilizing activity, providing new insights for the development of more effective PZA-like drugs.


  • Open Access

    Identifying genetic determinants of Mycobacterium tuberculosis acid growth arrest by transposon mutagenesis coupled with next-generation sequencing (Tn-seq)

    by Claire Healy, Thomas R. Ioerger, Sabine Ehrt, Alexandre Gouzy

    Mycobacterium tuberculosis, the causative agent of tuberculosis, remains the leading global infectious disease killer. Adaptation of Mycobacterium tuberculosis to acidic niches within the host during infection is vital to establish the disease. Here, we present a high-density transposon mutant sequencing library data set identifying genetic determinants of acid growth arrest to serve as a resource.

  • Open Access

    Unraveling Mycobacterium tuberculosis acid resistance and pH homeostasis mechanisms

    by Janïs Laudouze, Stéphane Canaan, Alexandre Gouzy, Pierre Santucci

    Mycobacterium tuberculosis (Mtb) is a successful pathogen that has developed a variety of strategies to survive and replicate within host cells. Among them, resistance mechanisms that allow Mtb to cope with the acidic environment of the endolysosomal network play a crucial role in its host adaptation and pathogenesis. In this Review, we summarize our understanding regarding the molecular factors contributing to Mtb acid resistance and the maintenance of intrabacterial pH homeostasis within in vitro and in cellulo systems. We also discuss some of the recently emerged concepts regarding host adaptation to acid stress, with a special emphasis on central carbon metabolism. Finally, we introduce some of the current and future direction(s) in this fast‐evolving field of research.


  • Open Access

    An exacerbated phosphate starvation response triggers Mycobacterium tuberculosis glycerol utilization at acidic pH

    by Claire Healy, Sabine Ehrt, Alexandre Gouzy

    The mechanisms controlling Mycobacterium tuberculosis (Mtb) replication and survival inside its human host remain ill-defined. Phagosome acidification and nutrient deprivation are common mechanisms used by macrophages to restrict the replication of intracellular bacteria. Mtb stops replicating at mildly acidic pH (pstA1 , a gene coding for a subunit of the Pst-1 system, results in the overexpression of the Pi starvation regulator regX3, which is sufficient to restore Mtb growth in acid conditions. Our data further support the role of limited glycerol uptake and ROS-mediated glyceraldehyde-3-phosphate dehydrogenase (GAPDH) inhibition in causing Mtb acid growth arrest. This study reveals an unexpected role of the Pi starvation response in regulating acid growth arrest and highlights the intricacy of the mechanisms regulating redox homeostasis, acid stress response, and nutrient utilization in Mtb. IMPORTANCE: Despite the availability of antibiotic treatment, M. tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains a major infectious disease killer worldwide. A better understanding of the environments that Mtb faces during infection and the mechanisms Mtb employs to respond and adapt may help identify currently unexplored pathways and targets for the development of novel anti-TB drugs. Here, we demonstrate that Mtb growth in acid can be restored by the over-expression of the Pi starvation response regulator regX3 . This work paves the way toward a better understanding of the mechanisms controlling Mtb growth at acidic pH and highlights the role of inorganic phosphate in this process.


  • Open Access

    Use of single-cell technology to improve our understanding of the role of TLR2 in macrophage– Mycobacterium tuberculosis interaction

    by Alexandre Gouzy

    The interaction between Mycobacterium tuberculosis , the agent of tuberculosis (TB), and its host cell, the macrophage, is multifaceted, dynamic, and involves multiple molecular partners. A better understanding of this interaction could help researchers manipulate the immune system in order to design host-targeted immunotherapies and/or develop a novel vaccine protecting better adults against TB. Jani and coworkers studied the role of the macrophage receptor TLR2 in the response to M. tuberculosis using single-cell technologies (C. Jani, S. L. Solomon, J. M. Peters, and S. C. Pringle, et al., mSystems, https://doi.org/10.1128/msystems.00052-23 , 2023). This work addresses the multiple challenges associated with such studies and shows how informative single-cell analysis can be for the study of heterogeneous and complex host-pathogen interactions.


  • Open Access

    Reliable detection of pyrazinamide antitubercular activity in vitro

    by Alexandre Gouzy, Claire Healy, Dirk Schnappinger, Sabine Ehrt

    Pyrazinamide (PZA) is a pivotal antibiotic for the chemotherapy of tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb). PZA is notorious for its poor in vitro activity which complicates phenotypic PZA-susceptibility testing (PPST) and likely causes inappropriate treatment of TB patients. Here, we show that PZA activity can be reliably detected using an acidic and lipid-rich culture medium mimicking conditions Mtb encounters during an infection. Our growth model could facilitate PPST to improve the treatment of TB patients and ameliorate the global surveillance of PZA resistance.


  • Open Access

    CinA mediates multidrug tolerance in Mycobacterium tuberculosis

    by Kaj M. Kreutzfeldt, Robert S. Jansen, Travis E. Hartman, Alexandre Gouzy, Ruojun Wang, Inna V. Krieger, Matthew D. Zimmerman, Martin Gengenbacher, Jansy P. Sarathy, Min Xie, et al.

    The ability of Mycobacterium tuberculosis (Mtb) to resist and tolerate antibiotics complicates the development of improved tuberculosis (TB) chemotherapies. Here we define the Mtb protein CinA as a major determinant of drug tolerance and as a potential target to shorten TB chemotherapy. By reducing the fraction of drug-tolerant persisters, genetic inactivation of cinA accelerated killing of Mtb by four antibiotics in clinical use: isoniazid, ethionamide, delamanid and pretomanid. Mtb ΔcinA was killed rapidly in conditions known to impede the efficacy of isoniazid, such as during nutrient starvation, during persistence in a caseum mimetic, in activated macrophages and during chronic mouse infection. Deletion of CinA also increased in vivo killing of Mtb by BPaL, a combination of pretomanid, bedaquiline and linezolid that is used to treat highly drug-resistant TB. Genetic and drug metabolism studies suggest that CinA mediates drug tolerance via cleavage of NAD-drug adducts.


  • Oxidative damage and delayed replication allow viable Mycobacterium tuberculosis to go undetected

    by Kohta Saito, Saurabh Mishra, Thulasi Warrier, Nico Cicchetti, Jianjie Mi, Elaina Weber, Xiuju Jiang, Julia Roberts, Alexandre Gouzy, Ellen Kaplan, et al.

    Mycobacterium tuberculosis that sustains moderate oxidative damage survives undetected on solid media, but growth delay restores replicative ability.